C. , M. May, F. E. Lennard, T. W. , W. et al., Determination of estrogen responsiveness of breast cancer by competitive reversetranscription-polymerase chain reaction, Brit. J. Cancer, vol.72, pp.1427-1434, 1995.

D. , R. Ribieras, S. Baldassini, S. Martin, V. Benzerara et al., Expression of an estrogen-induced breast-cancer-associated protein (pS2) in benign and malignant human ovarian cysts, Lab. Invest, vol.71, pp.188-192, 1994.

F. , L. S. Ostermeyer, E. A. Szabo, C. I. Dowd, P. Lynch et al., Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families, Nature, vol.8, pp.399-404, 1994.

G. , L. C. Johnson, B. L. Latour, A. M. Sulik, K. S. et al., Brca1 deficiency results in early embryonic lethality characterized by neuro-epithelial abnormalities, Nature, vol.12, pp.191-194, 1996.

G. , J. M. Nguyen, H. Li, T. , C. et al., Hormone-dependent regulation of BRCA1 in human breast-cancer cells, Cancer Res, vol.55, pp.4561-4565, 1995.

J. , J. M. Roberts, M. Schatz, C. Garnier, J. M. Brown et al., Structure of the human estrogen-responsive gene pS2, Nucleic Acid Res, vol.15, pp.1401-1414, 1983.

K. , T. Kononen, J. Johansson, O. Olsson, H. Borg et al., Detection of germline BRCA1 mutations in breast-cancer patients by quantitative messenger RNA in situ hybridization, Cancer Res, vol.56, pp.2912-2915, 1996.

L. , K. Borensztein, P. Ambu¨hlambu¨ambu¨hl, P. Froissart, M. Bichara et al., Chronic metabolic acidosis enhances NHE-3 protein abundance and transport activity in the rat thick limb by increasing NHE-3 mRNA, J. clin. Invest, vol.99, pp.24-30, 1997.

M. , S. T. Rajan, J. V. Wynshaw-boris, A. Xu, J. Yin et al., The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues, Nature, vol.11, pp.17-26, 1995.

M. , S. D. Pham, T. M. Caduff, R. F. Chen, M. Poy et al., Somatic mutations in the BRCA1 gene in sporadic ovarian tumours, Nature (Genet.), vol.9, pp.439-443, 1995.

P. , N. Torchard, D. Serova, O. M. Lynch, H. T. Feunten et al., 1-kb alu-mediated germ-line deletion removing BRCA1 exon 17, Cancer Res, vol.57, pp.828-831, 1997.

R. , R. Fink, D. J. Jiang, G. Prashant, D. Glorioso et al., Competitive quantitative PCR analysis of herpes-simplex- type-1 DNA and latency-associated transcript RNA in latently infected cells of rat brain, J. Virol, vol.68, pp.1864-1873, 1994.

R. , V. N. Shao, N. Ahmad, M. , R. et al., Anti-sense RNA to the putative tumor-suppressor gene BRCA1 transforms mouse fibroblasts, Oncogene, vol.12, pp.523-528, 1996.

R. , L. Jacquier, M. F. Daemi, N. Doré, J. F. et al., Comparative tumor morphogenesis of two human colon-adenocarcinoma cell clones xenografted in the immunosuppressed newborn rat, Differentiation, vol.54, pp.191-200, 1993.

S. , O. Montagna, M. Torchard, D. Narod, S. A. Tonin et al., A high incidence of BRCA1 mutations in 20 breast-ovarian-cancer families. Amer, J. hum. Genet, vol.58, pp.42-51, 1996.

T. , M. E. Jensen, R. A. Obermiller, P. O. Page, D. L. et al., Decreased expression of BRCA1 accelerates growth and is often present during breast cancer progression, Nature (Genet.), vol.9, pp.444-450, 1995.

W. , C. A. Payton, M. A. Elliott, G. S. Buaas, F. W. Cajulis et al., Differential subcellular localization expression and biological toxicity of BRCA1 and the splice variant BRCA1-11b, Oncogene, vol.14, pp.1-14, 1997.